Evidence map›Paper›PMID 31658303›Full record

ArticlePLoS pathogens2019

Nedd8 hydrolysis by UCH proteases in Plasmodium parasites.

Maryia Karpiyevich, Sophie Adjalley, Marco Mol, David B Ascher, Bethany Mason, Gerbrand J van der Heden van Noort, Heike Laman, Huib Ovaa, Marcus C S Lee, Katerina Artavanis-Tsakonas

Open access · goldAbstract read
In one paragraph

Article in PLoS pathogens, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 18 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
18citing papers in PubMed, 1 pooled it
1.4field-weighted citation impact, top 19% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

18 citing papers in PubMed, 1 synthesis or guideline pooled it, 30 citations in OpenAlex.

  1. Pooled it
  2. Article
  3. Article
  4. Article
  5. Review
  6. Article
  7. Article
  8. Article
  9. Article
  10. Using Graph-Based Signatures to Guide Rational Antibody Engineering.Methods in molecular biology (Clifton, N.J.) · 2023
    Article
  11. Article
  12. Article
  13. The emerging role of Deubiquitinases (DUBs) in parasites: A foresight review.Frontiers in cellular and infection microbiology · 2022
    Review
  14. PfMFR3: A Multidrug-Resistant Modulator inACS infectious diseases · 2021
    Article
  15. Article
  16. Article
  17. Review
  18. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 4 institutions in 3 countries.

Maryia KarpiyevichDepartment of Pathology, University of Cambridge, Cambridge, United Kingdom.
Sophie AdjalleyParasites and Microbes Programme, Wellcome Sanger Institute, Cambridge, United Kingdom.
Marco MolDepartment of Pathology, University of Cambridge, Cambridge, United Kingdom.ORCID 0000-0002-3722-2841
David B AscherDepartment of Biochemistry, University of Cambridge, Cambridge, United Kingdom.ORCID 0000-0003-2948-2413
Bethany MasonDepartment of Pathology, University of Cambridge, Cambridge, United Kingdom.ORCID 0000-0002-1157-0469
Gerbrand J van der Heden van NoortOncode Institute and Department of Cell and Chemical Biology, Leiden University Medical Centre, Leiden, The Netherlands.ORCID 0000-0001-5955-6431
Heike LamanDepartment of Pathology, University of Cambridge, Cambridge, United Kingdom.ORCID 0000-0002-6089-171X
Huib OvaaOncode Institute and Department of Cell and Chemical Biology, Leiden University Medical Centre, Leiden, The Netherlands.
Marcus C S LeeParasites and Microbes Programme, Wellcome Sanger Institute, Cambridge, United Kingdom.ORCID 0000-0002-4973-0915
Katerina Artavanis-TsakonasDepartment of Pathology, University of Cambridge, Cambridge, United Kingdom.ORCID 0000-0003-1164-1965
University of Cambridge · GBLeiden University · NLWellcome Sanger Institute · GBThe University of Melbourne · AU

Funding

Biotechnology and Biological Sciences Research Council BB/R001642/1Medical Research Council MR/M026302/1Wellcome TrustWellcome Trust 085054/Z/08/ZWellcome Trust 206194
6 · The paper itself

Abstract

Plasmodium parasites are the causative agents of malaria, a disease with wide public health repercussions. Increasing drug resistance and the absence of a vaccine make finding new chemotherapeutic strategies imperative. Components of the ubiquitin and ubiquitin-like pathways have garnered increased attention as novel targets given their necessity to parasite survival. Understanding how these pathways are regulated in Plasmodium and identifying differences to the host is paramount to selectively interfering with parasites. Here, we focus on Nedd8 modification in Plasmodium falciparum, given its central role to cell division and DNA repair, processes critical to Plasmodium parasites given their unusual cell cycle and requirement for refined repair mechanisms. By applying a functional chemical approach, we show that deNeddylation is controlled by a different set of enzymes in the parasite versus the human host. We elucidate the molecular determinants of the unusual dual ubiquitin/Nedd8 recognition by the essential PfUCH37 enzyme and, through parasite transgenics and drug assays, determine that only its ubiquitin activity is critical to parasite survival. Our experiments reveal interesting evolutionary differences in how neddylation is controlled in higher versus lower eukaryotes, and highlight the Nedd8 pathway as worthy of further exploration for therapeutic targeting in antimalarial drug design.

Indexed as

Amino Acid SequenceAntimalarialsCell LineHEK293 CellsHumansHydrolysisMalaria, FalciparumNEDD8 ProteinPlasmodium falciparumUbiquitinationUbiquitin-Protein LigasesUbiquitin ThiolesteraseAntimalarialsNEDD8 ProteinUbiquitin-Protein LigasesUbiquitin ThiolesteraseUCHL5 protein, human

Identifiers

PMID31658303
PMCPMC6837540
OpenAlexW2981425684

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.